265 related articles for article (PubMed ID: 24864174)
1. Treatment of mycoplasma pneumonia: a systematic review.
Biondi E; McCulloh R; Alverson B; Klein A; Dixon A; Ralston S
Pediatrics; 2014 Jun; 133(6):1081-90. PubMed ID: 24864174
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Mulholland S; Gavranich JB; Chang AB
Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Mulholland S; Gavranich JB; Gillies MB; Chang AB
Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children.
Gavranich JB; Chang AB
Cochrane Database Syst Rev; 2005 Jul; (3):CD004875. PubMed ID: 16034954
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Gardiner SJ; Gavranich JB; Chang AB
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD004875. PubMed ID: 25566754
[TBL] [Abstract][Full Text] [Related]
6. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.
Wang K; Gill P; Perera R; Thomson A; Mant D; Harnden A
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD009175. PubMed ID: 23076954
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Mycoplasma pneumoniae in pediatric lower respiratory infection.
Colin AA; Yousef S; Forno E; Korppi M
Pediatrics; 2014 Jun; 133(6):1124-5. PubMed ID: 24864169
[No Abstract] [Full Text] [Related]
8. Mycoplasma pneumoniae infections--does treatment help?
Spuesens EB; Meyer Sauteur PM; Vink C; van Rossum AM
J Infect; 2014 Nov; 69 Suppl 1():S42-6. PubMed ID: 25267596
[TBL] [Abstract][Full Text] [Related]
9. Mycoplasma pneumoniae and Legionella pneumophila in community-acquired lower respiratory tract infections among hospitalized children: diagnosis by real time PCR.
Maltezou HC; La-Scola B; Astra H; Constantopoulou I; Vlahou V; Kafetzis DA; Constantopoulos AG; Raoult D
Scand J Infect Dis; 2004; 36(9):639-42. PubMed ID: 15370649
[TBL] [Abstract][Full Text] [Related]
10. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
11. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia.
Fischer JE; Steiner F; Zucol F; Berger C; Martignon L; Bossart W; Altwegg M; Nadal D
Arch Pediatr Adolesc Med; 2002 Oct; 156(10):1005-8. PubMed ID: 12361446
[TBL] [Abstract][Full Text] [Related]
12. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
Lung DC; Yip EK; Lam DS; Que TL
Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials.
Kim HS; Sol IS; Li D; Choi M; Choi YJ; Lee KS; Seo JH; Lee YJ; Yang HJ; Kim HH
BMC Pulm Med; 2019 Dec; 19(1):251. PubMed ID: 31852460
[TBL] [Abstract][Full Text] [Related]
14. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
Ouchi K
Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
[TBL] [Abstract][Full Text] [Related]
15. Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.
Gilbert DN
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S121-2. PubMed ID: 18986276
[TBL] [Abstract][Full Text] [Related]
16. Mycoplasma pneumoniae P1 Genotype Indicates Severity of Lower Respiratory Tract Infections in Children.
Rodman Berlot J; Krivec U; Mrvič T; Kogoj R; Keše D
J Clin Microbiol; 2021 Jul; 59(8):e0022021. PubMed ID: 33980654
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of Mycoplasma pneumoniae in children.
Rogozinski LE; Alverson BK; Biondi EA
Minerva Pediatr; 2017 Apr; 69(2):156-160. PubMed ID: 28178776
[TBL] [Abstract][Full Text] [Related]
18. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
[TBL] [Abstract][Full Text] [Related]
19. [Value of clinical signs in the identification of Mycoplasma pneumonia in community acquired pneumonia in children].
Zhao D; Chen H; Yang Q; Deng L
Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):104-10. PubMed ID: 26875460
[TBL] [Abstract][Full Text] [Related]
20. Mycoplasma pneumonia in young children, 2-5 years of age.
Bunnag T; Lochindarat S; Srisan P; Jetanachai P
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S124-7. PubMed ID: 19253507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
